ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Opiant Pharmaceuticals, Inc. and Consort Medical plc Announce Manufacturing Agreement for OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
September 13, 2018Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, and Consort Medical plc (“Consort”) (LSE: CSRT), a leading contract development and manufacturing organization, today
Pharma Sources Insight January 2025
